FDA accepts Pfizer’s new CRC drug application & more: 3 GI industry key notes

Here are three updates from gastroenterology companies and practices from the past week:

Advertisement

The FDA accepted Pfizer’s supplemental New Drug Application for its combination therapy for advanced BRAF-mutant metastatic colorectal cancer and granted it priority review designation.

Check-Cap reported final results from its U.S. pilot study of its C-Scan System, a preparation-free colorectal cancer detection system.

Hattiesburg, Miss.-based Forrest General Hospital added Porter Glover, MD, Telciane Vesa, MD, and Andrew Weeks, MD, to its gastroenterology care team.

More articles on surgery centers:
Robotics might not be worth the ‘tremendous’ investment for ASCs — 2 leaders explain why
12 ASCs adding total joint replacements in 2019
Crystal Clinic Orthopedic Center celebrates northeast Ohio opening

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.